253 related articles for article (PubMed ID: 11052968)
21. Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging.
Miyatake Y; Mishima Y; Tsutsumi R; Otani T; Suemasa N; Masumoto S; Kuroda M; Sakaue H
Biochem Biophys Res Commun; 2020 Jul; 528(3):499-505. PubMed ID: 32513534
[TBL] [Abstract][Full Text] [Related]
22. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Iozzo P; Jarvisalo MJ; Kiss J; Borra R; Naum GA; Viljanen A; Viljanen T; Gastaldelli A; Buzzigoli E; Guiducci L; Barsotti E; Savunen T; Knuuti J; Haaparanta-Solin M; Ferrannini E; Nuutila P
Gastroenterology; 2007 Feb; 132(2):531-42. PubMed ID: 17258736
[TBL] [Abstract][Full Text] [Related]
23. Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers.
Rönnemaa EM; Rönnemaa T; Utriainen T; Raitakari M; Laine H; Takala T; Pitkänen OP; Kirvelä O; Knuuti J; Nuutila P
Metabolism; 1999 Feb; 48(2):239-44. PubMed ID: 10024089
[TBL] [Abstract][Full Text] [Related]
24. Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats.
Holmäng A; Mimura K; Björntorp P; Lönnroth P
Diabetes; 1997 Nov; 46(11):1799-804. PubMed ID: 9356029
[TBL] [Abstract][Full Text] [Related]
25. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
27. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
Ng CK; Soufer R; McNulty PH
J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
[TBL] [Abstract][Full Text] [Related]
28. Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects.
Slimani L; Oikonen V; Hällsten K; Savisto N; Knuuti J; Nuutila P; Iozzo P
J Clin Endocrinol Metab; 2006 Sep; 91(9):3394-403. PubMed ID: 16772346
[TBL] [Abstract][Full Text] [Related]
29. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
30. The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose.
Hasselbalch SG; Holm S; Pedersen HS; Svarer C; Knudsen GM; Madsen PL; Paulson OB
J Cereb Blood Flow Metab; 2001 Aug; 21(8):995-1002. PubMed ID: 11487735
[TBL] [Abstract][Full Text] [Related]
31. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
[TBL] [Abstract][Full Text] [Related]
33. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET.
Kelley DE; Williams KV; Price JC
Am J Physiol; 1999 Aug; 277(2):E361-9. PubMed ID: 10444433
[TBL] [Abstract][Full Text] [Related]
34. Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin-resistant skeletal muscle of patients with type 1 diabetes.
Peltoniemi P; Yki-Järvinen H; Oikonen V; Oksanen A; Takala TO; Rönnemaa T; Erkinjuntti M; Knuuti MJ; Nuutila P
Diabetes; 2001 Jun; 50(6):1371-7. PubMed ID: 11375338
[TBL] [Abstract][Full Text] [Related]
35. Time course of skeletal muscle glucose uptake during euglycemic hyperinsulinemia in the anesthetized rabbit: a fluorine-18-2-deoxy-2-fluoro-D-glucose study.
Mossberg KA; Taegtmeyer H
J Nucl Med; 1992 Aug; 33(8):1523-9. PubMed ID: 1634945
[TBL] [Abstract][Full Text] [Related]
36. Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET.
Reinhardt M; Beu M; Vosberg H; Herzog H; Hübinger A; Reinauer H; Müller-Gärtner HW
J Nucl Med; 1999 Jun; 40(6):977-85. PubMed ID: 10452314
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
Nuutila P; Knuuti J; Ruotsalainen U; Koivisto VA; Eronen E; Teräs M; Bergman J; Haaparanta M; Voipio-Pulkki LM; Viikari J
Am J Physiol; 1993 May; 264(5 Pt 1):E756-62. PubMed ID: 8498497
[TBL] [Abstract][Full Text] [Related]
38. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
[TBL] [Abstract][Full Text] [Related]
39. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E
J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329
[TBL] [Abstract][Full Text] [Related]
40. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects.
Sjöstrand M; Holmäng A; Strindberg L; Lönnroth P
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1097-103. PubMed ID: 11052965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
